SAN DIEGO--(BUSINESS WIRE)--Accelrys, Inc. (NASDAQ: ACCL), a leading provider of enterprise cheminformatics software, announced the addition of Pfizer to the Accelrys Enterprise Cheminformatics Consortium (“Consortium”). The Consortium will be a collaborative software development project led by Accelrys in partnership with a group of commercial member organizations. Its goal is to prioritize, design, and develop enterprise cheminformatics software components and services to allow members to implement industry-leading cheminformatics systems. The Consortium will commence in early 2007 and have a three year duration.